日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli Putative phosphotransferase IIA component sgcA (sgcA) CSB-YP340086ENV
CSB-EP340086ENV
CSB-BP340086ENV
CSB-MP340086ENV
CSB-EP340086ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli N-acetylneuraminate epimerase (nanM) CSB-YP340087ENV
CSB-EP340087ENV
CSB-BP340087ENV
CSB-MP340087ENV
CSB-EP340087ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli HTH-type transcriptional regulator YjiE (yjiE) CSB-YP340088ENV
CSB-EP340088ENV
CSB-BP340088ENV
CSB-MP340088ENV
CSB-EP340088ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yjiJ (yjiJ), partial CSB-YP340089ENV
CSB-EP340089ENV
CSB-BP340089ENV
CSB-MP340089ENV
CSB-EP340089ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Multidrug resistance protein MdtM (mdtM), partial CSB-YP340090ENV
CSB-EP340090ENV
CSB-BP340090ENV
CSB-MP340090ENV
CSB-EP340090ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli L-galactonate transporter (yjjL), partial CSB-YP340091ENV
CSB-EP340091ENV
CSB-BP340091ENV
CSB-MP340091ENV
CSB-EP340091ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transcriptional activator protein BglJ (bglJ) CSB-YP340092ENV
CSB-EP340092ENV
CSB-BP340092ENV
CSB-MP340092ENV
CSB-EP340092ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized deoxyribonuclease YjjV (yjjV) CSB-YP340093ENV
CSB-EP340093ENV
CSB-BP340093ENV
CSB-MP340093ENV
CSB-EP340093ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Adult enhancer factor 1 (Aef1) CSB-YP340094DLU
CSB-EP340094DLU
CSB-BP340094DLU
CSB-MP340094DLU
CSB-EP340094DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage T4 Uncharacterized 29.0 kDa protein in dda-modA intergenic region (y01B) CSB-YP340095EDZ
CSB-EP340095EDZ
CSB-BP340095EDZ
CSB-MP340095EDZ
CSB-EP340095EDZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage T4 Uncharacterized 18.3 kDa protein in modB-mrh intergenic region (y01F) CSB-YP340096EDZ
CSB-EP340096EDZ
CSB-BP340096EDZ
CSB-MP340096EDZ
CSB-EP340096EDZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter aerogenes Non-canonical purine NTP phosphatase CSB-YP340097EKN
CSB-EP340097EKN
CSB-BP340097EKN
CSB-MP340097EKN
CSB-EP340097EKN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Soluble lytic murein transglycosylase (slt) CSB-YP340098EKS
CSB-EP340098EKS
CSB-BP340098EKS
CSB-MP340098EKS
CSB-EP340098EKS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trp operon repressor (trpR) CSB-YP340099EKS
CSB-EP340099EKS
CSB-BP340099EKS
CSB-MP340099EKS
CSB-EP340099EKS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Ribonucleoside-diphosphate reductase 2 subunit alpha (nrdE) CSB-YP340100ENV
CSB-EP340100ENV
CSB-BP340100ENV
CSB-MP340100ENV
CSB-EP340100ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus elongatus Nitrate reductase (narB), partial CSB-YP340101FPY
CSB-EP340101FPY
CSB-BP340101FPY
CSB-MP340101FPY
CSB-EP340101FPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus acidocaldarius DNA-directed RNA polymerase subunit K (rpoK) CSB-YP340102FOZ
CSB-EP340102FOZ
CSB-BP340102FOZ
CSB-MP340102FOZ
CSB-EP340102FOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus acidocaldarius DNA-directed RNA polymerase subunit E (rpoE) CSB-YP340103FOZ
CSB-EP340103FOZ
CSB-BP340103FOZ
CSB-MP340103FOZ
CSB-EP340103FOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus acidocaldarius DNA-directed RNA polymerase subunit D (rpoD) CSB-YP340104FOZ
CSB-EP340104FOZ
CSB-BP340104FOZ
CSB-MP340104FOZ
CSB-EP340104FOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NADP-specific glutamate dehydrogenase (gdhA) CSB-YP340105FPJ
CSB-EP340105FPJ
CSB-BP340105FPJ
CSB-MP340105FPJ
CSB-EP340105FPJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×